aTyr Pharma Adds $12 Million
aTyr Pharma, a San Diego-based drug company focused on developing a novel class of naturally-occurring protein biologics for therapeutic applications, has raised $12 million in third-round funding. Return backers include Alta Partners, Cardinal Partners and Polaris Ventures. The company has now raised around $24 million.
28 July 2009•4 mins read
